Crowdonomics
SeqOnce Biosciences Inc

Reg CF · SAFE · Feb 2025

ClosedReached targetReg CFSAFE
via Republic · last checked Oct 8, 2026View campaign
Raised
$117.5K / $1.2M max
10% of ceiling
Investors
67
$1.8K avg
Valuation cap
$25M
cap, not an agreed valuation

Financials disclosed in this offering

FY2022–FY2023 · hover for source
$16.7M
−$1.5M
FY2022
$2.6M
−$2.3M
FY2023
RevenueNet income
Metric
FY2022 reviewed
FY2023 reviewed
Income statement
Revenue
$16,656,372
$2,585,633
Cost of goods sold
$11,095,933
$207,519
Gross margin
33%
92%
Net income
-$1,530,863
-$2,337,090
Taxes paid
$0
$0
Balance sheet
Cash
$4,435,703
$254,512
Accounts receivable
$259,793
$329,358
Total assets
$7,068,829
$2,688,956
Short-term debt
$3,008,600
$1,496,972
Long-term debt
$0
$0
Total liabilities
$3,008,600
$1,496,972
Other
Headcount
—
11

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Valuation cap$25M
Conversion discount20%

Offering details

Target$50,000
Max$1,235,000
Min investment—
OpenedFeb 18, 2025
DeadlineApr 30, 2025
ClosedApr 30, 2025
Days active71

Links & provenance

Source: SEC EDGAR
0001655808-25-000001
Last synced Aug 19, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.